Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease
- 1 October 2003
- journal article
- Published by Wiley in Movement Disorders
- Vol. 18 (10) , 1208-1209
- https://doi.org/10.1002/mds.10551
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson’s diseaseBiological Psychiatry, 2002
- The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementiaMovement Disorders, 2002
- Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson’s diseaseNeurology, 2000
- Olanzapine and clozapineNeurology, 2000
- Clozapine and Risperidone Treatment of Psychosis in Parkinson's DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2000
- Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's diseaseMovement Disorders, 2000
- Worsening of motor features of Parkinsonism with olanzapineMovement Disorders, 1999
- Quetiapine for the treatment of drug-induced psychosis in Parkinson's diseaseMovement Disorders, 1999
- Risperidone in levodopa‐induced psychosis in advanced parkinson's disease: An open‐label, long‐term studyMovement Disorders, 1997
- ParkinsonismNeurology, 1967